🇺🇸 SARS-CoV-2 Vaccine in United States
197 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 197
Most-reported reactions
- Covid-19 — 41 reports (20.81%)
- Off Label Use — 38 reports (19.29%)
- Pain — 17 reports (8.63%)
- Neutropenia — 16 reports (8.12%)
- Pneumonia — 16 reports (8.12%)
- Drug Ineffective — 15 reports (7.61%)
- Anaemia — 14 reports (7.11%)
- Nausea — 14 reports (7.11%)
- Arthralgia — 13 reports (6.6%)
- Diarrhoea — 13 reports (6.6%)
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is SARS-CoV-2 Vaccine approved in United States?
SARS-CoV-2 Vaccine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for SARS-CoV-2 Vaccine in United States?
Hospitales Universitarios Virgen del Rocío is the originator. The local marketing authorisation holder may differ — check the official source linked above.